# Remotely Administered Diet Intervention to Impact Symptom Burden in Myeloproliferative Neoplasm

> **NCT04744974** · PHASE2 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 28 (actual)

## Conditions studied

- Myeloproliferative Neoplasm

## Interventions

- **BEHAVIORAL:** Diet intervention

## Key facts

- **NCT ID:** NCT04744974
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-21
- **Primary completion:** 2021-12-06
- **Final completion:** 2021-12-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04744974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04744974, "Remotely Administered Diet Intervention to Impact Symptom Burden in Myeloproliferative Neoplasm". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04744974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*